A new study has highlighted “severe adverse events” associated with mifaprystone, also known as “abortion pills”.
MifePristone is a “pregnancy inhibitor” that is used in combination with another drug, misoprostol to eliminate pregnancy, according to the Mayo Clinic.
It is also used to manage early miscarriage, as it helps the body to prepare the uterus to empty.
The use of abortion pill has increased in recent years, new report shows: ‘adequate increase’
Research by the Ethics and Public Policy Center at Washington, DC has revealed that the rate of serious side effects indicated on the drug label approved by the FDA is 22 times higher.
After undergoing miscarriage aided by mifaprystone, about 11% of women experience more than one in -10- “infection, bleeding, or another serious or life-threatening phenomenon”, according to the study summary.
A new study has highlighted “severe adverse events” associated with mifaprystone, also known as “abortion pills”. (Istock)
The study used the data of insurance claims that include more than 865,000 drug abortion prescribed between 2017 and 2023, resulting in described as the largest dataset on chemical abortion.
Abortion on demand: These 6 states allow women to receive medicines for the end of pregnancy by phone or online
“Conversely, the current FDA-ensuing drug label is based on the results of 10 clinical trials with a total of 30,966 women, with less than 0.5 percent of which allegedly experienced severe adverse reactions,” the study has said.
“Some of these tests were conducted for a long time 42 years ago.”
Study Author – Director of Data Analysis of Jamie Brian Hall, EPPC, and Ryan T. Anderson, President of EPPC – called the results “really shocking and tragic reality”.
The study used data of insurance claims for more than 865,000 drug abortion prescribed between 2017 and 2023.
In a statement sent to Fox News Digital, the authors said, “We were not surprised by these conclusions, because other studies of small datasets have found significant security problems with chemical abortion drugs – especially after Obama and Biden administration, significant FDA safety was removed, when the chemical abortion was approved,” a statement was sent to the chemical abortion, “a statement was sent by the authors. said in.
“The biggest limit, which we are working to address, is that there is no insurance code for death – and sadly we know that women die from the complications arising from an abortion pill.”
According to the study summary, about 11% of women reported to experience “infection, bleeding, or another serious or life-threatening event”. (Istock)
Based on the study, the researchers are calling the FDA to restore the original security security that it was necessary when they approved mifepristone, saying that “women deserve the truth.”
Christina Francis, MD, CEO of the American Association of Pro Life Obugins, which is located in the feet. Wayne, Indiana, was not involved in research, but commented on the importance of the result.
Click here to get Fox News app
“The findings of this study, which analyzes about 900,000 drug-induced abortion, have aligned with what I have seen in my two decades of practice, during which I have taken care of many women, who have been lying about the safety of abortion drugs and faced significant complications from them,” he explained the Fox News Digital.
Francis concluded that around 71,000 women faced such serious complications in 2023, based on numbers from the Gutmacher Institute.
Mifepristone is also used to manage early miscarriage, as it helps the body to prepare to empty the uterus. (Istock)
He said, “It should work as a wake-up call for the FDA that the rate of complexity is 20 times higher than the pre-stated mentioned-and there is a public health crisis that should be investigated immediately,” he said.
“Women are worth consent about the dangers of the potential life-threatening of these drugs.”
Potential limits
Professor JC Hill, a health law expert at the case Western Reserve University in Cleveland, Ohio, also reviewed the findings of the study.
He said that 25 years ago, Mifepristone is one of the most studied drugs since its acceptance in the US, claiming that it is “one of the safest.”
Click here to sign up for our health newspaper
Hill said that the study of EPPC is not a review of the colleague and has questioned its “possible bias”.
“The study uses data of insurance claims, but the insurance claims are an incomplete proxy for medical results,” he explained to Fox News Digital. “They often have a lack of reference – for example, a claim for bleeding, may rarely not be associated with mifaprystone.”
According to the Golotcher Institute, about 63% of the US had drug abortion in the US in 2023. (Istock)
Hill also objected to the comparison of the data of modern claims for FDA’s clinical testing data.
“Clinical trials have rigid standards to define and report adverse events. Claim data bills arise for the objectives, not scientific analysis, and often for overcount or miscalance events.”
“Insurance claims are an incomplete proxy for medical results.”
Hill also stated that the legal standard for FDA drug regulation is “no risk”, and that all drugs have adverse event rates.
“The profit by reducing risks without profit distorts the regulatory structure,” he said.
For more health articles, go to www.foxnews.com/health
According to the Golotcher Institute, about 63% of the US had drug abortion in the US in 2023. This was an increase in 2020 by 53%.
Fox News reached the manufacturer of Digital FDA and Mifepristone for comments.
